Aorta atresia

Summary

Aorta atresia (MONDO:0001863) is a disease. A subtype of aortic disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	aorta atresia
Mondo ID	MONDO:0001863
DOID	DOID:14037
ICD-10-CM	Q25.2
SNOMED CT	204431007
UMLS	C0345010
MedGen	576689
Is cancer (heuristic)	no

Also known as: congenital atresia and stenosis of aorta

Disease family

This is a subtype of aortic disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › cardiovascular disorder › vascular disorder › arterial disorder › aortic disorder › aorta atresia

Related subtypes (16): aortic atherosclerosis, renal artery disease, superior mesenteric artery syndrome, aortic valve disorder, aortic malignant tumor, aortic aneurysm, tricuspid valve stenosis, aortitis, tricuspid valve prolapse, aorta coarctation, subaortic stenosis, membranous, aneurysm of sinus of Valsalva, neoplasm of aortic body, Leriche syndrome, X-linked severe syndromic thoracic aortic aneurysm and dissection, fibromuscular dysplasia of the renal arteries

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.